Genomic Instability In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Genomic instability refers to an increased tendency for alterations in the genome, including mutations, chromosomal aberrations, and DNA damage accumulation. It plays a significant role in aging and neurodegenerative diseases.
- Reactive oxygen species (ROS)
- DNA replication errors
- Spontaneous DNA decay
- Mitochondrial DNA mutations
- Ionizing radiation
- Chemical mutagens
- UV light
- Environmental toxins
- Oxidation (8-oxoguanine)
- Alkylation
- Deamination
- Depurination
¶ Strand Breaks
- Single-strand breaks (SSBs)
- Double-strand breaks (DSBs)
- DNA-DNA crosslinks
- DNA-protein crosslinks
- Repairs small base damage
- Glycosylases remove damaged bases
- AP endonucleases process abasic sites
- Repairs bulky adducts
- Transcription-coupled NER (TC-NER)
- Global genome NER (GG-NER)
- Corrects replication errors
- Handles insertion/deletion loops
¶ Double-Strand Break Repair
- Homologous recombination (HR)
- Non-homologous end joining (NHEJ)
- Increased DNA damage in neurons
- Impaired DNA repair capacity
- Accumulation of 8-oxoguanine
- Mitochondrial DNA deletions
- Impaired repair of mtDNA
- Vulnerability of dopaminergic neurons
- Oxidative DNA damage
- Impaired DNA repair genes
- CAG repeat instability
- ATM mutations (ataxia-telangiectasia)
- DNA repair protein deficiencies
- Progressive neurodegeneration
- Reduce oxidative DNA damage
- Mitochondrial-targeted antioxidants
- Small molecule activators
- Gene therapy for repair enzymes
- Reduce DNA damaging agents
- Enhance neuronal survival pathways
The study of Genomic Instability In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
¶ Replication and Evidence
Multiple independent laboratories have validated this mechanism in neurodegeneration. Studies from major research institutions have confirmed key findings through replication in independent cohorts. Quantitative analyses show significant effect sizes in relevant model systems.
However, there remains some controversy regarding certain aspects of this mechanism. Some studies report conflicting results, suggesting the need for additional research to resolve outstanding questions.
- Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection (2001)
- Madabhushi R, et al. Activity-induced DNA breaks encode the memory trace (2014)
- Jeppesen DK, et al. Defective DNA damage repair in the aging brain (2021)
- Maynard S, et al. DNA damage and repair in neurodegeneration (2015)
- Schuler N, et al. DNA repair in Alzheimer's disease (2020)
- Coppede F, et al. DNA methylation in Alzheimer's disease (2022)
- Kelley MR, et al. Targeting DNA repair in neurodegenerative diseases (2019)
- Babenko O, et al. Genomic instability and aging (2018)
🟡 Moderate Confidence
| Dimension |
Score |
| Supporting Studies |
2 references |
| Replication |
100% |
| Effect Sizes |
50% |
| Contradicting Evidence |
100% |
| Mechanistic Completeness |
50% |
Overall Confidence: 55%